Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice

Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cell Infect Microbiol
Autors principals: Yang, Lianjun, Liu, Bin, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Liu, Jinshi, Su, Zhihai, Wang, Min, Cui, Zhifei, Wang, Tingxuan, Zhang, Weicong, Li, Qingchu, Lu, Hai
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Cellular and Infection Microbiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://ncbi.nlm.nih.gov/pubmed/30886835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2019.00044
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars